Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Eur J Oral Sci ; 132(1): e12957, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37908149

ABSTRACT

Stress substantially increases the risk of developing painful temporomandibular disorders (TMDs) by influencing the release of endogenous catecholamines. Propranolol, an antagonist of ß-adrenergic receptors, has shown potential in alleviating TMD-associated pain, particularly when the level of catecholamines is elevated. The aim of this study was to explore whether intra-articular propranolol administration is effective in diminishing temporomandibular joint (TMJ) pain during repeated stress situations. Additionally, we investigated the effect of repeated stress on the expression of genes encoding ß-adrenoceptors in the trigeminal ganglion. In the present study, rats were exposed to a stress protocol induced by sound, then to the administration of formalin in the TMJ (to elicit a nociceptive response), followed immediately afterward by different doses of propranolol, after which the analgesic response to propranolol was evaluated. We also assessed the levels of beta-1 and beta-2 adrenergic receptor mRNAs (Adrb1 and Adrb2, respectively) using reverse transcription-quantitative PCR (RT-qPCR). Our findings revealed that propranolol administration reduces formalin-induced TMJ nociception more effectively in stressed rats than in non-stressed rats. Furthermore, repeated stress decreases the expression of the Adrb2 gene within the trigeminal ganglion. The findings of this study are noteworthy as they suggest that individuals with a chronic stress history might find potential benefits from ß-blockers in TMD treatment.


Subject(s)
Propranolol , Temporomandibular Joint , Rats , Animals , Propranolol/adverse effects , Temporomandibular Joint/metabolism , Rats, Wistar , Pain , Catecholamines/metabolism , Catecholamines/pharmacology , Catecholamines/therapeutic use , Formaldehyde/adverse effects , Formaldehyde/metabolism
2.
Sci Rep ; 10(1): 10160, 2020 06 23.
Article in English | MEDLINE | ID: mdl-32576879

ABSTRACT

A previous study demonstrated that a high-fat diet (HFD), administered for one-three-days, induces hypothalamic inflammation before obesity's established, and the long term affects leptin signaling/action due to inflammation. We investigate whether exposure to particulate matter of a diameter of ≤2.5 µm (PM2.5) in mice fed with a chow diet leads to similar metabolic effects caused by high-fat feeding. Compared to the filtered air group (FA), one-day-exposure-PM2.5 did not affect adiposity. However, five-days-exposure-PM2.5 increased hypothalamic microglia density, toll-like-receptor-4 (Tlr4), and the inhibitor-NF-kappa-B-kinase-epsilon (Ikbke) expression. Concurrently, fat mass, food intake (FI), and ucp1 expression in brown adipose tissue were also increased. Besides, decreased hypothalamic STAT3-phosphorylation and Pomc expression were found after twelve-weeks-exposure-PM2.5. These were accompanied by increased FI and lower energy expenditure (EE), leading to obesity, along with increased leptin and insulin levels and HOMA. Mechanistically, the deletion of Tlr4 or knockdown of the Ikbke gene in the hypothalamus was sufficient to reverse the metabolic outcomes of twelve-weeks-exposure-PM2.5. These data demonstrated that short-term exposure-PM2.5 increases hypothalamic inflammation, similar to a HFD. Long-term exposure-PM2.5 is even worse, leading to leptin resistance, hyperphagia, and decreased EE. These effects are most likely due to chronic hypothalamic inflammation, which is regulated by Tlr4 and Ikbke signaling.


Subject(s)
Air Pollution/adverse effects , Hypothalamus/metabolism , Hypothalamus/pathology , Inflammation/etiology , Leptin/metabolism , Microglia/pathology , Obesity/etiology , Particulate Matter/adverse effects , Adipocytes, Brown/metabolism , Animals , Energy Metabolism/drug effects , Gene Expression , Hyperphagia/etiology , Hypothalamus/drug effects , I-kappa B Kinase/genetics , I-kappa B Kinase/metabolism , Inflammation/genetics , Mice, Transgenic , Microglia/drug effects , Obesity/metabolism , Signal Transduction/drug effects , Time Factors , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism , Uncoupling Protein 1/genetics , Uncoupling Protein 1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...